Back to results
Active, not recruitingPhase 2

Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

NCT03775096

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Michele L Lima Gregorio

Los Angeles, California, United States

View on ClinicalTrials.gov
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136) — TrialFind